Perez-Santos Martin

24PUBLICATIONS
18CO-AUTHORS
Molecular targetsGene and molecular therapyMarketing research methodologyRegenerative medicine (incl. stem cells)Ngā pūtaiao Māori kāore anō kia whakarōpūhia i wāhi kē (Māori sciences not elsewhere classified)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 08, 2026
LAG-3 antagonists for cancer treatment: an updated patent review (2020-2025).

Martín Pérez-Santos, Gerardo Landeta, Maricruz Anaya-Ruiz

|Oct 26, 2024
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615.

Cindy Bandala, Donaciano Flores-Robles, Pavel Sierra-Martínez

|Jan 10, 2024
Patenting trends by Mexican pharmaceutical companies.

Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde

|Nov 20, 2023
Drug repurposing of rimantadine for treatment of cancer.

Nemesio Villa-Ruano, Vianey Marin-Cevada, Gabriela Sanchez-Esgua

|Oct 06, 2023
Drug repurposing of mito-atovaquone for cancer treatment.

Nemesio Villa-Ruano, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz

|Feb 01, 2023
Patenting trends in the pharmaceutical field of Mexican universities.

Gabriela Sanchez-Esgua, Juan Reyes-Alvarez, Martin Perez-Santos

Pageof 4

Frequent Collaborators

14 joint publications

Maricruz Anaya-Ruiz

5 joint publications

Cindy Bandala

5 joint publications

Luis Villafaña-Diaz

4 joint publications

Gabriela Sanchez-Esgua